Trial Profile
A Dose-Ranging, Phase II, Open Label Study of ATN 161 in Advanced Renal Cell Cancer
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 15 Jan 2008
Price :
$35
*
At a glance
- Drugs ATN 161 (Primary)
- Indications Renal cancer
- Focus Therapeutic Use
- 07 Nov 2006 Status change
- 25 Nov 2005 New trial record.